> ## Content Index
> Fetch the complete content index at: https://www.intercepta.ai/blog/llms.txt
> Use this file to discover other available public pages before exploring further.

# Hidden Advertisements in Health Marketing: Four Regulators Are Closing In
- URL: https://www.intercepta.ai/blog/hidden-ads-disclosure-rules-ftc-asa-cma/
- Published: 2026-08-13T09:00:00.000Z
- Updated: 2026-08-13T13:20:24.000Z
- Description: Hidden ads and undisclosed reviews now breach four regulators' rules: ASA, CMA, FCA and FTC. What health marketers must disclose before they publish.
- Author: Edward Sweigart
- Tags: Healthcare, Compliance, Advertising, Regulatory

*In one ruling this summer, the Advertising Standards Authority found that a health advertiser had dressed its own marketing as an independent review. On its own, it is only a single ruling. The failure behind it, content that does not disclose it is marketing, is now policed by four regulators across the United Kingdom and the United States, and a claim can be accurate yet the way it is presented might breach the rules.*

On 29 July 2026, the UK Advertising Standards Authority (ASA) upheld a ruling against an online pharmacy over its paid social advertising for weight-loss treatment. The advertising had been presented as an independent review of weight-loss products. The ASA found that presenting the pharmacy’s own marketing as a neutral review breached the Code’s recognition requirement. The same ruling separately found that the advertising promoted prescription-only medicines to the public. An earlier piece, [‘The Edge of the Advertising Rules Is Not Where Companies Think’](https://www.intercepta.ai/blog/asa-rulings-15-july-2026/), examined that issue and how far the advertising rules now reach beyond the advertisement itself.

The focus here is the recognition failure. For compliance and marketing teams in the health and wellness sectors, the significance is less in the single finding than in what it represents. The same failure, marketing that conceals its commercial origin, is now written into the requirements of four regulators. The ASA and the Competition and Markets Authority (CMA) police it in the United Kingdom. The Financial Conduct Authority (FCA) applies the same duty to financial promotions. In the United States, the Federal Trade Commission (FTC) enforces it by rule. Four regulators now impose the same requirement that content disclose what it is.

![Four cards side by side showing that the ASA, CMA, FCA and FTC each require marketing content to disclose what it is, with the specific rule for each regulator underneath its name.](https://www.intercepta.ai/blog/content/images/2026/08/Week-13---Blog-Fig-1-Four-Regulators-One-Requirement--2400x1400-.png)

Four regulators, one requirement. The specific rule each carries, side by side.

## The page called itself a review site. The advertiser owned it.

The ruling this summer is a clean illustration of the recognition failure in practice. The advertising appeared under a page name a reader would take to mean an independent review site offering unbiased reviews of weight-loss products. Its price comparisons, claiming the best prices in the market, reinforced that impression of a neutral site weighing up the options. The advertiser in fact owned and operated the page and had placed the advertising itself. On these facts, the ASA concluded the marketer had falsely implied it was acting for purposes outside its business and had failed to make its commercial intent clear, in breach of CAP Code rule 2.3\. The finding did not depend on any individual claim being inaccurate. The failure was that the reader could not see who was speaking.

## Advertising cannot hide what it is

The advertising rules begin from a simple requirement. Rule 2.1 of the Committee of Advertising Practice (CAP) Code states that “marketing communications must be obviously identifiable as such”. This rule applies to all marketing, whatever the medium, and it is indifferent to the accuracy of the claims. Two further rules sharpen it. A marketer may not falsely present itself as a consumer, or as acting for reasons unconnected with its own business, and where content does not obviously read as commercial, the marketer has to say that it is. Advertisement features or material designed to read like editorial must still be recognisable as advertising, and that expectation reaches influencer posts that resemble ordinary content. The rules address the hidden origin of the content, not the quality of any single claim within it.

## Affiliates and influencers hide it too

An advertiser-owned review page is one form the failure takes. Affiliate and influencer content is another, and one that health and wellness marketing leans on heavily. A post from a trusted voice about a supplement, a treatment or a programme carries weight precisely because it reads as personal experience rather than paid promotion. A post that does not make it clear that it is commissioned or paid will fail the same recognition requirement. The obligation is straightforward in principle. Content that promotes a product in exchange for payment or benefit must be identifiable as advertising, prominently and up front, so that a reader knows they are viewing marketing before they act on it. The wellness sector concentrates the risk because the products often turn on trust and testimony, and the audiences are frequently reached through exactly the personal, editorial-seeming formats the rules were written to cover.

![Two panels side by side, one for an advertiser-owned review page and one for an undisclosed influencer or affiliate, each listing the signals to look for and showing that both patterns break the same recognition rule.](https://www.intercepta.ai/blog/content/images/2026/08/Week-13---Blog-Fig-2-Two-Failure-Patterns--2400x1400-.png)

Two failure patterns, one rule. Both break the recognition requirement, with different tells.

## A second regulator can now fine the concealment directly

The same failure has a longer history in consumer law. The Consumer Protection from Unfair Trading Regulations 2008 banned traders from posing as consumers, or concealing the commercial purpose behind their content. On 6 April 2025, the unfair commercial practices provisions of the Digital Markets, Competition and Consumers Act 2024, enforced by the CMA, replaced those Regulations. The Act restates the 2008 ban, adds new banned practices on reviews, and gives the CMA the power to fine directly. Fake reviews, and reviews that conceal the fact they were incentivised, are now a banned commercial practice, automatically unfair regardless of their effect. Incentivised reviews remain lawful only where the incentive is disclosed. The ban reaches the people who write and commission the reviews, content creators and influencers among them. It also extends beyond individual reviews to the aggregate rating a business displays, its overall score, review count and ranking. Anyone who publishes reviews carries a positive duty to take reasonable and proportionate steps to prevent and remove fake and concealed incentivised reviews. The failure the ASA described as a recognition breach has a close statutory sibling here. Practice 25 of Schedule 20, restated from the 2008 Regulations, captures falsely giving the impression that a trader is not acting in the course of business, or presenting a business as a consumer. In substance, it is the conduct the ASA found under its own recognition rule. The Act allows the CMA to impose a penalty for a substantive breach of up to the greater of £300,000 or 10% of a business’s global annual turnover, directly, without going to court.

## Financial promotions must be identifiable

The requirement is not confined to advertising law. Financial services has its own version. Under the FCA’s rules, a financial promotion must be clearly identifiable as such, the direct equivalent of the advertising recognition rule. For insurance, the duty is set out in its own terms. In relation to insurance distribution, marketing communications must always be clearly identifiable as marketing. A health insurer marketing cover to the public therefore faces the underlying test the ASA applied to the weight-loss review page, that is, whether a reader can recognise the marketing as marketing. The regulator and the sourcebook differ, but the failure is the same.

## The United States polices it too

The pattern extends across the Atlantic. In the United States, the FTC enforces the same failure by rule. Its Rule on the Use of Consumer Reviews and Testimonials, in force since October 2024, makes it an unfair or deceptive practice for a business to materially misrepresent that a website or entity it controls provides independent reviews about a category that includes its own products. It is the weight-loss review page again, described in American law, and the rule carries civil penalties for each violation. The FTC’s Endorsement Guides cover the influencer half. They set out how the prohibition on deceptive practices applies to endorsements. A material connection between an endorser and a business is one a reader would not expect, and one that could affect the weight or credibility given to the endorsement. Such a connection must be disclosed clearly and conspicuously. The health sector is squarely in view. In November 2023 the FTC warned two trade associations and a dozen dietitians and other health influencers that their social-media posts on sugar and sweeteners did not adequately disclose that the influencers were paid, noting that consumers give particular weight to the opinions of health professionals. The FTC warned rather than fined, but the principle it applied is the one running through every example here.

## The claim is examined. The presentation is not

There is a common thread here that matters for how content is reviewed before it is published. None of these failures is visible in the truth of the claim. A price comparison can be accurate, or a testimonial can be sincere, yet each can still breach the rules because the content does not disclose that it is marketing, that it was paid for, or that the reviewer is the seller. Accuracy is a regulatory requirement for any individual claim. Recognition is a property of the whole presentation, of what the content signals, who is speaking and why. A review process built solely to substantiate claims before publication therefore works claim by claim, and it will pass content that the ASA, the CMA, the FCA or the FTC would not. The question these regimes ask is whether a reader can recognise the content for what it is, and see who stands behind it, even when every claim in it is accurate. Substantiation is its own test, examined in the companion piece [Clinically Proven, Except It Was Not](https://www.intercepta.ai/blog/ftc-substantiation-clinically-proven/).

![Two columns showing what a claims-only review examines, price accuracy, testimonial sincerity, benefit substantiation, alongside what it does not examine, whether the content is disclosed as marketing, whether it is disclosed as paid, and whether the reviewer is the seller.](https://www.intercepta.ai/blog/content/images/2026/08/Week-13---Blog-Fig-3-Claim-vs-Presentation--2400x1400-.png)

The claim is examined. The presentation is not. What a claims-only review catches, and what it does not.

## Validate before you publish

Intercepta AI validates marketing content against 1,100+ regulatory rules across the United States, United Kingdom, European Union, Canada, Australia and New Zealand. Each scan returns a documented report that maps each issue to the specific regulation it references, with remediation guidance for your compliance team to review. Marketing teams validate before publication. Compliance teams hold a documented regulatory record. Every decision on every finding stays with your compliance team.

[Your first three scans are free](https://intercepta.ai/?ref=intercepta.ai)

*No payment method required.*

## Sources

- [Advertising Standards Authority, ruling on paid social advertising for weight-loss treatment, complaint reference A26-1335405, 29 July 2026](https://www.asa.org.uk/codes-and-rulings/rulings.html?ref=intercepta.ai) (upheld on two grounds, breach of the recognition-of-marketing rule, and promoting prescription-only medicines to the public)
- Committee of Advertising Practice, CAP Code (Edition 12), rules 2.1, 2.3 and 2.4 (recognition of marketing communications)
- Digital Markets, Competition and Consumers Act 2024, Chapter 1 of Part 4 (unfair commercial practices) and Schedule 20 (banned practices, including paragraph 13 on fake and concealed incentivised reviews and practice 25 on falsely implying a trader is not acting in the course of business); in force 6 April 2025 by S.I. 2025/272; monetary penalties under Part 3
- Consumer Protection from Unfair Trading Regulations 2008 (S.I. 2008/1277), Schedule 1, paragraph 22 (falsely claiming or creating the impression that the trader is not acting for purposes relating to his trade, business, craft or profession, or falsely representing oneself as a consumer), revoked and restated by the 2024 Act
- Competition and Markets Authority, Fake reviews guidance (CMA208), 4 April 2025
- Financial Conduct Authority Handbook, COBS 4.3.1R (financial promotions to be identifiable as such) and ICOBS 2.2.2A R (insurance marketing communications must always be clearly identifiable as such)
- Federal Trade Commission, Rule on the Use of Consumer Reviews and Testimonials, 16 CFR Part 465 (effective 21 October 2024), including 16 CFR 465.6 on company-controlled review websites
- Federal Trade Commission, Guides Concerning the Use of Endorsements and Testimonials in Advertising, 16 CFR Part 255 (revised effective 26 July 2023)
- Federal Trade Commission, staff warning letters to two trade associations and a dozen health influencers on inadequate disclosure of material connections, 13 November 2023